Research News and Research

RSS

Views on abortion debate: Akin's defiance hurts Romney; Sen. Snowe on mending the GOP's image

Rep. Todd Akin doesn't look like he's going away. And that's a problem for Mitt Romney, the presumed Republican nominee. Akin's open defiance makes Romney look like a figurehead. After Romney joined other Republican Party leaders urging Akin to step down as the Republican Senate candidate in Missouri, Akin told the nominee to mind his own business. "Don't you think he may have built this thing up and made a bigger deal about it than he needed to?" Akin said on Sean Hannity's radio show. "Why couldn't he run his race and I'll run mine?"

28 Aug 2012

Morphotek commences MORAb-004 Phase II metastatic soft tissue sarcoma trial

Morphotek, Inc. announced today that it has commenced a multi-center, Phase II study evaluating the safety and efficacy of MORAb-004 when combined with gemcitabine and docetaxel in the treatment of metastatic soft tissue sarcoma.

28 Aug 2012

Viewpoints: Health law will leave some poor families 'in lurch'; Mich. Gov.'s effort to get health exchange

Confusing language in the health care reform law has raised the possibility that millions of Americans living on modest incomes may be unable to afford their employers' family policies and yet fail to qualify for government subsidies to buy their own insurance. This is a bizarre development that undercuts the basic goal of health care reform - to expand the number of insured people and make their coverage affordable.

28 Aug 2012

Leg compressions after stroke appear to trigger natural protective mechanisms that reduce damage

Successive, vigorous bouts of leg compressions following a stroke appear to trigger natural protective mechanisms that reduce damage, researchers report.

28 Aug 2012

FDA approves Gilead’s Stribild to treat HIV-1 infection

The U.S. Food and Drug Administration today approved Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate), a new once-a-day combination pill to treat HIV-1 infection in adults who have never been treated for HIV infection.

28 Aug 2012

Short sleep duration linked to more aggressive breast cancers

Lack of sleep is linked to more aggressive breast cancers, according to new findings published in the August issue of Breast Cancer Research and Treatment by physician-scientists from University Hospitals Case Medical Center's Seidman Cancer Center and Case Comprehensive Cancer Center at Case Western Reserve University.

28 Aug 2012

Neuralstem completes NSI-566 Phase I trial on amyotrophic lateral sclerosis

Neuralstem, Inc. announced the completion of the Phase I trial of its NSI-566 spinal cord neural stem cells for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), with the eighteenth patient treated.

28 Aug 2012

Roundup: Ga. AIDS Drug Assistance waiting list at zero; Mass. signs up for health law's disabled adults program

The state has eliminated a waiting list for a program that provides lifesaving medications to thousands of low-income, uninsured Georgians with HIV/AIDS more than two years after the list was first started. Established in July 2010, the wait list for Georgia's AIDS Drug Assistance Program rapidly ballooned to more than 1,600 -- at one time becoming the largest in the country. A spike in the need for the program was largely fueled by the economic downturn as people lost their jobs and health insurance.

28 Aug 2012

Women with severe aortic stenosis less likely to die following TAVI

Women with severe aortic stenosis are 40% less likely to die after transcatheter aortic valve implantation (TAVI) than men, reveals the latest data from the largest study to date of gender differences in outcomes after TAVI.

27 Aug 2012

BioTime amends license agreement with University of Utah for HyStem technology

BioTime, Inc. announced that the company has amended its license from the University of Utah to expand the field of use for which BioTime is licensed to produce and market products covered by the core patents underlying HyStem technology.

27 Aug 2012

Political cartoon: 'Opening Act?'

Kaiser Health News provides a fresh take on health policy developments with "Opening Act?" by John Deering.

27 Aug 2012

Insulin glargine retards progression of atherosclerosis in high-risk people

A sub-study of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial, designed to investigate the effect of insulin glargine and omega-3 fatty acids on atherosclerosis progression, has found that, compared to standard care, only insulin glargine (a long-acting insulin) had a "modest" statistically non-significant reducing effect on the primary outcome of rate of change in maximum carotid intima media thickness (CIMT) at 12 carotid sites.

27 Aug 2012

Renal denervation leads to better outcomes than standard drug treatment in patients with AHF

Renal denervation leads to better outcomes than standard drug treatment in patients with advanced heart failure, according to research presented at ESC Congress 2012. The results of the Olomouc I pilot study were presented by Dr Miloš Táborský from the University Hospital Olomouc.

27 Aug 2012

BD announces acquisition of Sirigen

BD, a leading global medical technology company, announced today that it has acquired Sirigen Group Limited, a developer of unique polymer dyes that are used in flow cytometry and can be applied to other technologies.

From BD (Becton, Dickinson and Company) 27 Aug 2012

Update on Merck's development programs for vorapaxar, ER niacin/laropirprant and anacetrapib

Merck today provided an update on the development programs for vorapaxar, extended release niacin/laropirprant (MK524A, Tredaptive) and anacetrapib in association with the European Society of Cardiology (ESC) meeting in Munich.

27 Aug 2012

Healthy foods consumed more often by the wealthy than poor

Healthy foods such as fruits and vegetables, proteins and non-saturated fats are consumed more often by the wealthy while poorer people consume more carbohydrates, concludes a new study involving people from 17 countries.

27 Aug 2012

New method helps engineer tissues with embedded nanoscale networks

A multi-institutional research team has developed a method for embedding networks of biocompatible nanoscale wires within engineered tissues. These networks—which mark the first time that electronics and tissue have been truly merged in 3D—allow direct tissue sensing and potentially stimulation, a potential boon for development of engineered tissues that incorporate capabilities for monitoring and stimulation, and of devices for screening new drugs.

27 Aug 2012

CardioDx completes two-tranche equity financing

CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced the completion of a $58 million two-tranche equity financing.

27 Aug 2012

Regulating microbes could help prevent diseases associated with obesity

Vaccines and antibiotics may someday join caloric restriction or bariatric surgery as a way to regulate weight gain, according to a new study focused on the interactions between diet, the bacteria that live in the bowel, and the immune system.

27 Aug 2012

Spironolactone should be considered as a treatment option in hypertensive patients with DHF

Mineralocorticoid receptor antagonists should be considered as a treatment option in hypertensive patients with diastolic heart failure, said Professor Burkert Pieske presenting results today of the Aldosterone Receptor Blockade in Diastolic Heart Failure (Aldo-DHF) study at ESC Congress 2012.

27 Aug 2012

Research News and Research

Views on abortion debate: Akin's defiance hurts Romney; Sen. Snowe on mending the GOP's image

Morphotek commences MORAb-004 Phase II metastatic soft tissue sarcoma trial

Viewpoints: Health law will leave some poor families 'in lurch'; Mich. Gov.'s effort to get health exchange

Leg compressions after stroke appear to trigger natural protective mechanisms that reduce damage

FDA approves Gilead’s Stribild to treat HIV-1 infection

Short sleep duration linked to more aggressive breast cancers

Neuralstem completes NSI-566 Phase I trial on amyotrophic lateral sclerosis

Roundup: Ga. AIDS Drug Assistance waiting list at zero; Mass. signs up for health law's disabled adults program

Women with severe aortic stenosis less likely to die following TAVI

BioTime amends license agreement with University of Utah for HyStem technology

Political cartoon: 'Opening Act?'

Insulin glargine retards progression of atherosclerosis in high-risk people

Renal denervation leads to better outcomes than standard drug treatment in patients with AHF

BD announces acquisition of Sirigen

Update on Merck's development programs for vorapaxar, ER niacin/laropirprant and anacetrapib

Healthy foods consumed more often by the wealthy than poor

New method helps engineer tissues with embedded nanoscale networks

CardioDx completes two-tranche equity financing

Regulating microbes could help prevent diseases associated with obesity

Spironolactone should be considered as a treatment option in hypertensive patients with DHF

A guide to advancing biotherapeutic research eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery